Price $4.95 |
Market Cap
322.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
2.99
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-198.1K
|
FCF
-0.7
|
|
Op. Margin
-211.70%
|
Net Margin
-264.50%
|
ROE
450.40%
|
ROI
650.10%
|
|
ROA
-64.10%
|
EPS Growth
-665.20%
|
Current Ratio
1.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Rockwell Medical Inc (RMTI) | $3.04 | - | - | 55M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $0.13 | - | - | 8.4M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.59 | - | - | 1.2M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
